Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$100,048,993
+$33,152,902 QoQ
Shares Held
1,720,533
+15.3% QoQ
Ownership
1.78%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 11.059944796176534.ToString("F0")%
Shared 0.05230937157264638.ToString("F0")%
None 88.88774583225081.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. XENE ranks #68 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in XENE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100,048,993 | 1,720,533 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $66,896,091 | 1,492,550 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $58,878,650 | 1,466,467 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $43,208,398 | 1,380,460 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,253,551 | 305,620 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $11,317,902 | 288,722 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $11,004,426 | 279,513 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $9,623,199 | 246,812 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $10,445,652 | 242,640 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $10,457,462 | 227,040 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,254,559 | 212,370 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,183,175 | 212,550 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,424,850 | 207,456 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,784,901 | 197,436 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $6,150,393 | 170,371 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $5,999,462 | 197,221 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $5,257,642 | 171,987 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,037,418 | 161,249 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,252,990 | 147,447 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,431,678 | 130,595 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,755,775 | 98,088 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $1,436,276 | 93,386 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $991,285 | 89,547 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $1,086,766 | 86,664 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $215,210 | 18,978 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||